[Hemolytic disorders and venous thrombosis: An update]

Area of Science:

• Hematology
• Vascular Medicine
• Pathophysiology

Background:

• Hemolytic diseases present a complex risk for venous thrombosis.
• Mechanisms underlying this association vary, with some linked to hemolysis itself and others to specific disease pathologies.
• Despite progress, the interplay between hemolysis and thrombosis remains incompletely understood.

Purpose of the Study:

• To elucidate the primary pro-thrombotic mechanisms in hemolytic conditions.
• To consolidate current clinical data on hemolysis-associated venous thrombosis.
• To clarify the link between hemolysis and increased thrombotic risk.

Main Methods:

• Literature review of pro-thrombotic mechanisms in hemolysis.
• Synthesis of clinical data on venous thrombosis in hemolytic diseases.
• Focus on specific hemolytic pathologies: paroxysmal nocturnal hemoglobinuria, hemoglobinopathies, autoimmune hemolytic anemia, and thrombotic microangiopathies.

Main Results:

• Multiple factors contribute to venous thrombosis risk in hemolytic diseases.
• Mechanisms include general hemolytic effects and disease-specific pathways.
• Clinical data highlights significant thrombotic risk across various hemolytic conditions.

Conclusions:

• Clarifying pro-thrombotic mechanisms in hemolysis is essential for clinical practice.
• Understanding disease-specific pathways aids in risk stratification for venous thrombosis.
• Further research is needed to fully unravel the complex relationship between hemolysis and thrombosis.